324 related articles for article (PubMed ID: 27415006)
1. Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry.
Park SD; Moon J; Kwon SW; Suh YJ; Kim TH; Jang HJ; Suh J; Park HW; Oh PC; Shin SH; Woo SI; Kim DH; Kwan J; Kang W
PLoS One; 2016; 11(7):e0159416. PubMed ID: 27415006
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Combined Dysglycemia and Hypoxic Liver Injury on Admission in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (from the INTERSTELLAR Cohort).
Jang HJ; Oh PC; Moon J; Suh J; Park HW; Park SD; Lee K; Kim JS; Lee HJ; Choi RK; Choi YJ; Kang WC; Kwon SW; Kim TH
Am J Cardiol; 2017 Apr; 119(8):1179-1185. PubMed ID: 28214004
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Oh PC; Eom YS; Moon J; Jang HJ; Kim TH; Suh J; Kong MG; Park SD; Kwon SW; Choe JY; Suh SY; Lee K; Han SH; Ahn T; Kang WC
PLoS One; 2020; 15(5):e0233286. PubMed ID: 32442225
[TBL] [Abstract][Full Text] [Related]
4. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
5. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
[TBL] [Abstract][Full Text] [Related]
6. Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
Moon J; Suh J; Oh PC; Lee K; Park HW; Jang HJ; Kim TH; Park SD; Kwon SW; Kang WC
Am J Cardiol; 2016 Jul; 118(2):177-82. PubMed ID: 27236252
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
Marenzi G; Cosentino N; Moltrasio M; Rubino M; Crimi G; Buratti S; Grazi M; Milazzo V; Somaschini A; Camporotondo R; Cornara S; De Metrio M; Bonomi A; Veglia F; De Ferrari GM; Bartorelli AL
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385429
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Silvain J; Nguyen LS; Spagnoli V; Kerneis M; Guedeney P; Vignolles N; Cosker K; Barthelemy O; Le Feuvre C; Helft G; Collet JP; Montalescot G
Heart; 2018 May; 104(9):767-772. PubMed ID: 29092921
[TBL] [Abstract][Full Text] [Related]
9. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD
Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470
[TBL] [Abstract][Full Text] [Related]
10. Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention.
Margolis G; Gal-Oz A; Letourneau-Shesaf S; Khoury S; Keren G; Shacham Y
J Nephrol; 2018 Jun; 31(3):423-428. PubMed ID: 29185210
[TBL] [Abstract][Full Text] [Related]
11. Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.
Zeller M; Labalette-Bart M; Juliard JM; Potier L; Feldman LJ; Steg PG; Cottin Y; Roussel R
Int J Cardiol; 2016 Oct; 220():137-42. PubMed ID: 27376570
[TBL] [Abstract][Full Text] [Related]
12. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
[TBL] [Abstract][Full Text] [Related]
13. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
14. Heart failure is the strongest predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Matějka J; Varvařovský I; Rozsíval V; Herman A; Bláha K; Večeřa J; Lazarák T; Novotný V; Mužáková V; Vojtíšek P
Kardiol Pol; 2016; 74(1):18-24. PubMed ID: 26101023
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
[TBL] [Abstract][Full Text] [Related]
17. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
[TBL] [Abstract][Full Text] [Related]
18. Predictors of acute kidney injury (AKI) in high-risk ST-elevation myocardial infarction (STEMI) patients: A single-center retrospective observational study.
Sinkovič A; Masnik K; Mihevc M
Bosn J Basic Med Sci; 2019 Feb; 19(1):101-108. PubMed ID: 30589402
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
[TBL] [Abstract][Full Text] [Related]
20. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
Araujo GN; Pivatto Junior F; Fuhr B; Cassol EP; Machado GP; Valle FH; Bergoli LC; Wainstein RV; Polanczyk CA; Wainstein MV
Cardiovasc Interv Ther; 2018 Jul; 33(3):224-231. PubMed ID: 28540634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
